http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170010302-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_832231e56616a3e87c01de72bb8aaeba |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2814 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2835 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5058 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2016-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca96cbf72688df41dba96bb2cb45b46d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd9016c6e5b6911d390fe5948b58fc04 |
| publicationDate | 2017-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20170010302-A |
| titleOfInvention | A pharmaceutical composition for preventing or treating neurodegenerative diseases comprising inhibitor for expressing or activating of SHP-1/-2 |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating degenerative brain diseases comprising an agent capable of inhibiting the expression or activity of SHP-1 / -2, a method for preventing or treating degenerative brain diseases by administering the above pharmaceutical composition, A composition for diagnosing a degenerative brain disease, a kit for diagnosing a degenerative brain disease comprising the diagnostic composition, and a method for providing information for diagnosing a degenerative brain disease using the kit or the kit. Since the agent capable of inhibiting the expression or activity of SHP-1 / -2 of the present invention can inhibit signal transduction caused by the transfer of? -Sinuclene to the adjacent cells, the cell of? -Sinuclene Can be usefully used as a therapeutic agent for degenerative brain diseases by reducing toxic effects. Further, the agent capable of inhibiting the expression or activity of SHP-1 / -2 of the present invention can be an important clue to elucidate the pathogenesis of degenerative brain diseases. Therefore, It can be used to overcome the disease. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021125810-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021125811-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11179397-B2 |
| priorityDate | 2015-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 146.